tiprankstipranks
Advertisement
Advertisement
BCAL buys 10.2% stake in Genetic Signatures to broaden diagnostics platform
PremiumCompany AnnouncementsBCAL buys 10.2% stake in Genetic Signatures to broaden diagnostics platform
1M ago
BCAL Diagnostics secures funding to drive cancer test commercialisation through FY2027
Premium
Company Announcements
BCAL Diagnostics secures funding to drive cancer test commercialisation through FY2027
1M ago
BCAL launches blood test to monitor breast cancer recurrence
Premium
Company Announcements
BCAL launches blood test to monitor breast cancer recurrence
2M ago
BCAL speeds national rollout of Avantect cancer blood tests
PremiumCompany AnnouncementsBCAL speeds national rollout of Avantect cancer blood tests
4M ago
BCAL Director Jayne Shaw Increases Shareholding via On‑Market Purchase
Premium
Company Announcements
BCAL Director Jayne Shaw Increases Shareholding via On‑Market Purchase
5M ago
BCAL Director Jayne Shaw Increases Shareholding Via On-Market Purchase
Premium
Company Announcements
BCAL Director Jayne Shaw Increases Shareholding Via On-Market Purchase
5M ago
BCAL Diagnostics Accelerates Commercial Rollout of Cancer Blood Tests and Targets Broader Market for BREASTESTplus
PremiumCompany AnnouncementsBCAL Diagnostics Accelerates Commercial Rollout of Cancer Blood Tests and Targets Broader Market for BREASTESTplus
6M ago
BCAL Diagnostics Ramps Up Cancer Test Launches as Clinical Data and Funding Strengthen Growth Plans
Premium
Company Announcements
BCAL Diagnostics Ramps Up Cancer Test Launches as Clinical Data and Funding Strengthen Growth Plans
7M ago
BCAL Diagnostics to Launch Nationwide Cancer Detection Tests in Australia
Premium
Company Announcements
BCAL Diagnostics to Launch Nationwide Cancer Detection Tests in Australia
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100